CLINICAL_TRIALS
trial_result
· 2022-03-18
Clinical Trial Update: Tretinoin Plus Interferon Alfa in Treating Patients With Metastatic Kidney Cancer [Phase 2]
Summary
Phase 2 trial update evaluating tretinoin in combination with interferon alfa for metastatic kidney cancer has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Weill Medical College of Cornell University | Conditions: Kidney Cancer | Phase 2 | Status: COMPLETED | Results posted: 2022-03-18